Immunolocalization of the ICE/Ced-3-family protease, CPP32 (Caspase-3), in non-Hodgkin's lymphomas, chronic lymphocytic leukemias, and reactive lymph nodes

Blood

Volumn 89, Issue 10, 1997, Pages 3817-3825

  Krajewski, Stanislaw ^b   Gascoyne, Randy D ^b   Zapata, Juan M ^b   Krajewska, Maryla ^b   Kitada, Shinichi ^b   Chhanabhai, Mukesh ^b   Horsman, Douglas ^b   Berean, Ken ^b   Piro, Lawrence D ^b   Fugier Vivier, Isabelle ^b   Liu, Yong Jun ^b   Wang, Hong Gang ^b   Reed, John C ^a  

^a BURNHAM INSTITUTE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINASE;

APOPTOSIS; ARTICLE; B LYMPHOCYTE; CHRONIC LYMPHATIC LEUKEMIA; CONTROLLED STUDY; ENZYME LOCALIZATION; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; LYMPH NODE HYPERPLASIA; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL;

EID: 18544400988     PISSN: 00064971     EISSN: None     Source Type: Journal    
DOI: 10.1182/blood.v89.10.3817     Document Type: Article

References (48)

1. Reed JC: Bcl-2 and the regulation of programmed cell death. J Cell Biol 124:1, 1994
2. Hockenbery DM, Nunez G, Milliman C, Schreiber RD, Korsmeyer SJ: Bcl-2 is an inner mitochondrial membrane protein that blocks programmed cell death. Nature 348:334, 1990
3. Vaux DL, Cory S, Adams JM: Bcl-2 gene promotes haemopoietic cell survival and cooperates with c-myc to immortalize pre-B cells. Nature 335:440, 1988
4. Tsujimoto Y, Croce CM: Analysis of the structure, transcripts, and protein products of bcl-2, the gene involved in human follicular lymphoma. Proc Natl Acad Sci USA 83:5214, 1986
5. Tsujimoto Y, Cossman J, Jaffe E, Croce C: Involvement of the bcl-2 gene in human follicular lymphoma. Science 228:1440, 1985
6. Hengartner MO, Horvitz HR: C. elegans cell survival gene ced-9 encodes a functional homolog of the mammlian proto-oncogene bcl-2. Cell 76:665, 1994
7. Shaham S, Horvitz HR: Developing Caenorhabditis elegans neurons may contain both cell-death protective and killer activities. Genes Dev 10:578, 1996
8. Xue D, Shaham S, Horvitz HR: The Caenorhabditis elegans cell-death protein CED-3 is a cysteine protease with substrate specificities similar to those of the human CPP32 protease. Genes Dev 10:1073, 1996
9. Yuan J, Shaham S, Ledoux S, Ellis HM, Horvitz HR: The C. elegans cell death gene ced-3 encodes a protein similar to mammalian interleukin-1 beta-converting enzyme. Cell 75:641, 1993
10. Jacobson MD, Evan GI: Apoptosis. Breaking the ICE. Curr Biol 4:337, 1994
11. Kumar S: ICE-like proteases in apoptosis. TIBS 20:198, 1995
12. Martin SJ, Green DR: Protease activation during apopotosis: Death by a thousand cuts? Cell 82:349, 1995
13. Alnemri ES, Livingston DJ, Nicholson DW, Salvesen G, Thornberry NA, Wong WW, Yuan J: Human ICE/CED-3 Protease Nomenclature. Cell 87:171, 1996
14. Tewari M, Quan LT, O'Rourke K, Desnoyers S, Zeng Z, Beidler DR, Poirier GG, Salvesen GS, Dixit VM: Yama/CPP32beta, a mammalian homolog of CED-3, is a crmA-inhibitable protease that cleaves the death substrate poly ADP-ribose polymerase. Cell 81:801, 1995
15. Nicholson DW, Ali A, Thornberry NA, Vaillancourt JP, Ding KC, Gallant M, Gareau Y, Griffin PR, Labelle M, Lazebnik YA, Munday NA, Raju SM, Smulson ME, Yamin T, Yu VL, Miller DK: Identification and inhibition of the ICE/CED-3 protease necessary for mammalian apoptosis. Nature 376:37, 1995
16. Liu X, Kim CN, Yang J, Jemmerson R, Wang X: Induction of apoptotic program in cell-free extracts: Requirement for dATP and Cytochrome C. Cell 86:147, 1996
17. Fernandes-Alnemri T, Litwack G, Alnemri ES: CPP32, a novel human apoptotic protein with homology to Caenorhabditis elegans cell death protein Ced-3 and mammalian interleukin-1 beta-converting enzyme. J Biol Chem 269:30761, 1994
18. Schlegel J, Peters I, Orrenius S, Miller DK, Thornberry NA, Yamin TT, Nicholson DW: CPP32/apopain is a key interluekin 1 beta converting enzyme-like protease involved in Fas-mediated apoptosis. J Biol Chem 271:1841, 1996
19. Armstrong R, Aja T, Xiang J, Gaur S, Krebs J, Hoang K, Bai X, Korsmeyer S, Karanewsky D, Fritz L, Tomaselli K: Fas-induced activation of the cell death related protease CPP32 is inhibited by Bcl-2 and by ICE family protease inhibitors. J Biol Chem 271:16850, 1996
20. An S, Knox KA: Ligation of CD40 rescues Ramos-Burkitt lymphoma B cells from calcium ionophore- and antigen receptor-triggered apoptosis by inhibiting activation of the cystein protease CPP32/Yama and cleavage of its substrate PARP. FEBS Lett 386:115, 1996
21. Gagliardini V, Fernandez PA, Lee RK, Drexler HC, Rotello RJ, Fishman MC, Yuan J: Prevention of vertebrate neuronal death by the crmA gene. Science 263:826, 1994
22. Tewari M, Telford WG, Miller RA, Dixit VM: CrmA, a poxvirus-encoded serpin, inhibits cytotoxic T-lymphocyte-mediated apoptosis. J Biol Chem 270:1, 1995
23. Enari M, Talanian RV, Wong WW, Nagata S: Sequential activation of ICE-like and CPP32-like proteases during Fas-mediated apoptosis. Nature 380:723, 1996
24. Sugimoto A, Friesen PD, Rothman JH: Baculovirus p35 prevents developmentally programmed cell death and rescues a ced-9 mutant in the nematode Caenorhabditis elgans. EMBO J 13:2023, 1994
25. Rabizadeh S, LaCount DJ, Friesen PD, Bredesen DE: Expression of the baculovirus p35 gene inhibits mammalian neural cell death. J Neurochem 270:16526, 1995
26. Moreno MB, Memon SA, Zacharchuk CM: Apoptosis signaling pathways in normal T cells: Differential activity of Bcl-2 and ICE-family protease inhibitors on glucocorticoid- and Fas-mediated cytotoxicity. J Immunol 157:3845, 1996
27. Boudreau N, Sympson CJ, Werb Z, Bissell MJ: Suppression of ICE and apoptosis in mammary epithelial cells by extracellular matrix. Science 267:891, 1995
28. Boulakia CA, Chen G, Ng FWH, Teodoro JG, Branton PE, Nicholson DW, Poirier GG, Shore GC: Bcl-2 and adenovirus E1B 19 kDA protein prevent E1A-induced processing of CPP32 and cleavage of poly(ADP-ribose) polymerase. Oncogene 12:29, 1996
29. L function upstream of the ced-3-like apoptotic proteases. J Biol Chem 271:4573, 1996
30. Liu Y-J, Mason DY, Johnson GD, Abbot S, Gregory CD, Hardie DL, Gordon J, MacLennan ICM: Germinal center cells express bcl-2 protein after activation by signals which prevent their entry into apoptosis. Eur J Immunol 21:1905, 1991
31. Choi MSK, Boise LH, Gottschalk AR, Quintans J, Thompson CB, Klaus GGB: The role of bcl-XL in CD40-mediated rescue from anti-mu-induced apoptosis in WEHI-231B lymphoma cells. Eur J Immunol 25:1352, 1995
32. Project TN-HsLPC: National Cancer Institute Sponsored Study of Classifications of Non-Hodgkin's Lymphomas. Cancer 49:2112, 1982
33. Harris NL, Jaffe ES, Stein H, Banks PM, Chan JKC, Cleary ML, Delsol G, DeWolf-Peeters C, Falini B, Gatter KC, Grogan TM, Isaacson PG, Knowles DM, Mason DY, Muller-Hermelink HK, Pileri SA, Piris MA, Ralfkiaer E, Warnke RA: A revised European-American classification of lymphoid neoplasms: A proposal from the International Lymphoma Study Group. Blood 85:1361, 1994
34. Mitelman F: Guidelines for Cancer Cytogenetics, Supplement to an International System for Human Cytogenetic Nomenclature. Basel, Switzerland, Karger, 1991
35. Liu Y, Barthelemy C, de Bouteiller O, Arpin C, Durand I, Banchereau J: Memory B cells from human tonsils colonize mucosal epithelium and directly present antigen to T cells by rapid up-regulation of B7-1 and B7-2. Immunity 2:239, 1995
36. Hanada M, Delia D, Aiello A, Stadtmauer E, Reed JC: Bcl-2 gene hypomethylation and high-level expression in B-cell chronic lymphocytic leukemia. Blood 82:1820, 1993
37. Krajewski S, Zapata JM, Reed JC: Detection of multiple antigens on Western blots. Anal Biochem 236:221, 1996
38. Krajewski S, Bodrug S, Gascoyne R, Berean K, Krajewska M, Reed JC: Immunohistochemical analysis of mcl-1 and bcl-2 proteins in normal and neoplastic lymph nodes. Am J Pathol 145:515, 1994
39. Krajewski S, Krajewska M, Shabaik A, Miyashita T, Wang H-G, Reed JC: Immunohistochemical determination of in vivo distribution of bax, a dominant inhibitor of bcl-2. Am J Pathol 145:1323, 1994
40. Reed JC, Krajewski S, Kitada S, Miyashita T: Methods of measuring Bcl-2 gene expression, in Green D (ed): Handbook of Experimental Immunology. 1996, p 128.1
41. Darmon AJ, Nicholson DW, Bleackley RC: Activation of the apoptotic protease CPP32 by cytotoxic T-cell-derived granzyme B. Nature 377:446, 1995
42. Wijsman JH, Jonker RR, Keijzer R, van de Velde CJH, Cornelisse CJ, van Dierendocnck JH: A new method to detect apoptosis in paraffin sections: In situ end-labeling of fragmented DNA. J Histochem Cytochem 41:7, 1993
43. Pezzella F, Tse AGD, Cordell JL, Pulford KAF, Gatter KC, Mason DY: Expression of the bcl-2 oncogene protein is not specific for the 14; 18 chromosomal translocation. Am J Pathol 137:225, 1990
44. Hockenbery DM, Zutter M, Hickey W, Nahm M, Korsmeyer SJ: Bcl-2 protein is topographically restricted in tissues characterized by apoptotic cell death. Proc Natl Acad Sci USA 88:6961, 1991
45. Duan H, Chinnaiyan AM, Hudson PL, Wings JP, He W, Dixit VM: ICE-LAP3, a novel mammalian homologue of the Caenorhabditis elegans cell death protein ced-3 is activated during Fas- and tumor necrosis factor-induced apoptosis. J Biol Chem 271:1621, 1996
46. Ezdinli EZ, Costello WG, Icli G, Lenhard RE, Johnson GJ, Silverstein M, Berard CW, Bennett JM, Carbone PP: Nodular mixed lymphocytic-histiocytic lymphoma. Cancer 45:261, 1980
47. Nathwani BN, Metter GE, Miller TP, Burke JS, Mann RB, Barcos M, Kjeldsberg CR, Dixon DO, Winberg CD, Whitcomb CC, Jones SE: What should be the morphologic criteria for the subdivision of follicular lymphomas? Blood 68:837, 1986
48. Pittaluga S, Bijnens L, Teodorovic I, Hagenbeek A, Meerwaldt JH, Somers R, Thomas J, Noordijk EM, DeWolf-Peeters C: Clinical Analysis of 670 Cases in two trials of the European Organization for the research and Treatment of Cancer Lymphoma Cooperative Group subtyped according to the Revised European-American Classification of Lymphoid Neoplasms: A comparison with the working formulation. Blood 87:4358, 1996